(Q55921808)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16039337%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

review article

1 reference

title

Sjögren's syndrome (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16039337%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

0 references

Robert I Fox

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16039337%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

language of work or name

English

0 references

publication date

1 July 2005

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16039337%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16039337%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

volume

366

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16039337%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

issue

9482

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16039337%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

page(s)

321-331

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16039337%20AND%20SRC:MED&resulttype=core&format=json

Estimating the prevalence among Caucasian women of primary Sjögren's syndrome in two general practices in Birmingham, UK.

31 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966990-5

7 January 2021

Current issues in the diagnosis and treatment of Sjögren's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966990-5

7 January 2021

Primary Sjögren syndrome in the paediatric age: a multicentre survey

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966990-5

7 January 2021

Sjögren's syndrome associated with systemic lupus erythematosus: clinical and laboratory profiles and comparison with primary Sjögren's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966990-5

7 January 2021

Prevalence of Sjögren's syndrome in a closed rural community

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966990-5

7 January 2021

Sicca symptoms, saliva and tear production, and disease variables in 636 patients with rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966990-5

7 January 2021

HLA and Autoimmunity in Scleroderma (Systemic Sclerosis)

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966990-5

7 January 2021

The European Community Study Group on diagnostic criteria for Sjögren's syndrome. Sensitivity and specificity of tests for ocular and oral involvement in Sjögren's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966990-5

7 January 2021

Classification criteria for Sjögren's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966990-5

7 January 2021

Range of antinuclear antibodies in “healthy” individuals

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966990-5

7 January 2021

Labial salivary gland biopsy in Sjögren's syndrome. Assessment as a diagnostic criterion in 362 suspected cases

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966990-5

7 January 2021

Prevalence and clinical significance of lymphocytic foci in minor salivary glands of healthy volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966990-5

7 January 2021

Genetically programmed development of salivary gland abnormalities in the NOD (nonobese diabetic)-scid mouse in the absence of detectable lymphocytic infiltration: a potential trigger for sialoadenitis of NOD mice

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966990-5

7 January 2021

Expression of the B cell-attracting chemokine CXCL13 in the target organ and autoantibody production in ectopic lymphoid tissue in the chronic inflammatory disease Sjögren's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966990-5

7 January 2021

"Lymphoid" chemokine messenger RNA expression by epithelial cells in the chronic inflammatory lesion of the salivary glands of Sjögren's syndrome patients: possible participation in lymphoid structure formation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966990-5

7 January 2021

Activation of arterial wall dendritic cells and breakdown of self-tolerance in giant cell arteritis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966990-5

7 January 2021

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966990-5

1 reference

7 January 2021

Recent advances in understanding molecular mechanisms in the pathogenesis and antibody profile of Sjögren’s syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966990-5

7 January 2021

The genetics of primary Sjögren’s syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966990-5

7 January 2021

Type-I interferon receptor deficiency reduces lupus-like disease in NZB mice

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966990-5

7 January 2021

Involvement of the interferon-gamma-induced T cell-attracting chemokines, interferon-gamma-inducible 10-kd protein (CXCL10) and monokine induced by interferon-gamma (CXCL9), in the salivary gland lesions of patients with Sjögren's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966990-5

7 January 2021

Increased salivary gland tissue expression of Fas, Fas ligand, cytotoxic T lymphocyte-associated antigen 4, and programmed cell death 1 in primary Sjögren's syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966990-5

7 January 2021

Peptide-containing nerves in labial salivary glands in Sjögren's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966990-5

7 January 2021

Defective cellular trafficking of lacrimal gland aquaporin-5 in Sjögren's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966990-5

7 January 2021

Abnormal distribution of aquaporin-5 water channel protein in salivary glands from Sjögren's syndrome patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966990-5

7 January 2021

A unified theory of the role of the ocular surface in dry eye.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966990-5

7 January 2021

Differential diagnosis of dry eye conditions

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966990-5

7 January 2021

The oral side of Sjögren syndrome. Diagnosis and treatment. A review

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966990-5

7 January 2021

The relationship between dental status and health-related quality of life in upper aerodigestive tract cancer patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966990-5

7 January 2021

Dental caries and dental health behavior of patients with primary Sjögren syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966990-5

7 January 2021

A pilot study to test the efficacy of oral administration of interferon-alpha lozenges to patients with Sjögren's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966990-5

7 January 2021

Up-regulation of M3-muscarinic receptors in labial salivary gland acini in primary Sjögren's syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966990-5

7 January 2021

Use of muscarinic agonists in the treatment of Sjögren's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966990-5

7 January 2021

M1 agonists for the treatment of Alzheimer's disease. Novel properties and clinical update

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966990-5

7 January 2021

Environmental illness: evaluation of salivary flow, symptoms, diseases, medications, and psychological factors

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966990-5

7 January 2021

Major salivary gland imaging

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966990-5

7 January 2021

A comparative study between MR sialography and salivary gland scintigraphy in the diagnosis of Sjögren syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966990-5

7 January 2021

The laryngeal and esophageal manifestations of Sjögren’s syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966990-5

7 January 2021

Cutaneous Vasculitis in Primary Sjögren Syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966990-5

7 January 2021

The arthropathy of Sjögren's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966990-5

7 January 2021

Sjögren's syndrome: current therapies remain inadequate for a common disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966990-5

7 January 2021

Pulmonary involvement in primary Sjögren's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966990-5

7 January 2021

Interstitial lung diseases associated with collagen vascular diseases: radiologic and histopathologic findings

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966990-5

7 January 2021

Severe interstitial pneumonitis associated with infliximab therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966990-5

7 January 2021

Interstitial pneumonitis following rituximab therapy for immune thrombocytopenic purpura (ITP)

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966990-5

7 January 2021

Cardiac manifestations in primary Sjögren's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966990-5

7 January 2021

Long-term outcome of mothers of children with complete congenital heart block

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966990-5

7 January 2021

Anti-La (SS-B) but not anti-Ro52 (SS-A) antibodies cross-react with laminin--a role in the pathogenesis of congenital heart block?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966990-5

7 January 2021

Sjögren autoantibodies modify neonatal cardiac function via M1 muscarinic acetylcholine receptor activation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966990-5

7 January 2021

Mesangial nephropathy in Sjögren's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966990-5

7 January 2021

Hypokalaemic paralysis as the presenting manifestation of primary Sjögren's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966990-5

7 January 2021

Renal tubular acidosis, Sjögren syndrome, and bone disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966990-5

7 January 2021

Progressive interstitial renal fibrosis due to Chinese herbs in a patient with calcinosis Raynaud esophageal sclerodactyly telangiectasia (CREST) syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966990-5

7 January 2021

Interstitial cystitis-like urinary symptoms among patients with Sjögren's syndrome: a population-based study in Finland.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966990-5

7 January 2021

Severe interstitial cystitis associated with Sjögren's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966990-5

7 January 2021

Subcellular distribution of aquaporin 5 in salivary glands in primary Sjögren's syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966990-5

7 January 2021

Autoantibodies in primary Sjögren's syndrome are directed against proteasomal subunits of the alpha and beta type

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966990-5

7 January 2021

Gastritis classified in accordance with the Sydney system in patients with primary Sjögren's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966990-5

7 January 2021

Impaired response of gastric MALT-lymphoma to Helicobacter pylori eradication in patients with autoimmune disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966990-5

7 January 2021

Antibody to carbonic anhydrase II is present in primary biliary cirrhosis (PBC) irrespective of antimitochondrial antibody status

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966990-5

7 January 2021

Autoimmune conditions associated with primary biliary cirrhosis: response to ursodeoxycholic acid therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966990-5

7 January 2021

High incidence and prevalence of adult coeliac disease. Augmented diagnostic approach

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966990-5

7 January 2021

Thyroid dysfunction in primary Sjögren's syndrome: a long-term followup study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966990-5

7 January 2021

Autoimmune thyroid disease in primary Sjögren's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966990-5

7 January 2021

Presence of systemic autoimmune disorders in patients with autoimmune thyroid diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966990-5

7 January 2021

Specific cellular immune responses to pancreatic antigen in chronic pancreatitis and Sj�gren's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966990-5

7 January 2021

Increased Risk of Lymphoma in Sicca Syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966990-5

7 January 2021

Malignant lymphoma in primary Sjögren's syndrome: a multicenter, retrospective, clinical study by the European Concerted Action on Sjögren's Syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966990-5

7 January 2021

Salivary gland MALT lymphoma associated with Helicobacter pylori infection in a patient with Sjögren's Syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966990-5

7 January 2021

Relationship between Sjögren's syndrome and human T-lymphotropic virus type I infection: follow-up study of 83 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966990-5

7 January 2021

Brief report: reversible lymphomas associated with Epstein-Barr virus occurring during methotrexate therapy for rheumatoid arthritis and dermatomyositis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966990-5

7 January 2021

Neurologic manifestations in primary Sjögren syndrome: a study of 82 patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966990-5

7 January 2021

Sensory neuropathy of the trigeminal, glossopharyngeal, and vagal nerves in Sjögren's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966990-5

7 January 2021

Peripheral neuropathy associated with sicca complex

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966990-5

7 January 2021

Ischemic optic neuropathy and high-level anticardiolipin antibodies in primary Sjögren's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966990-5

7 January 2021

Primary Sjögren's syndrome with central nervous system disease mimicking multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966990-5

7 January 2021

One hundred anti-Ro (SS-A) antibody positive patients: a 10-year follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966990-5

7 January 2021

The prevalence of Sjogren syndrome in patients with primary progressive multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966990-5

7 January 2021

Psychiatric symptoms before systemic lupus erythematosus is diagnosed.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966990-5

7 January 2021

Cerebral blood flow in Sjögren's syndrome using 99Tcm-HMPAO brain SPET

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966990-5

7 January 2021

Neuropsychiatric disease in Sjögren's syndrome: anti-ribosomal P and anti-neuronal antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966990-5

7 January 2021

The assessment of fatigue in primary Sjögren's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966990-5

7 January 2021

Treatment of primary Sjögren's syndrome with hydroxychloroquine

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966990-5

7 January 2021

Respiratory function in systemic lupus erythematosus: relation with activity and severity

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966990-5

7 January 2021

Hydroxychloroquine treatment for primary Sjögren's syndrome: a two year double blind crossover trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966990-5

7 January 2021

Interstitial lung disease in primary Sjögren's syndrome. Clinical-pathological evaluation and response to treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966990-5

7 January 2021

Management of lupus erythematosus: recent insights

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966990-5

7 January 2021

Effect of cyclosporin A (CyA) on the immunopathological lesion of the labial minor salivary glands from patients with Sjögren's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966990-5

7 January 2021

New concepts in treatment protocols for severe systemic vasculitis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966990-5

7 January 2021

RETRACTED: Infliximab in patients with primary Sjögren's syndrome: a pilot study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966990-5

7 January 2021

Etanercept in Sjögren's syndrome: a twelve-week randomized, double-blind, placebo-controlled pilot clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966990-5

7 January 2021

Treatment of refractory autoimmune diseases with ablative immunotherapy using monoclonal antibodies and/or high dose chemotherapy with hematopoietic stem cell support.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966990-5

7 January 2021

Biomarkers in systemic lupus erythematosus: II. Markers of disease activity

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966990-5

7 January 2021

10.1016/S0140-6736(05)66990-5

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16039337%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16039337%20AND%20SRC:MED&resulttype=core&format=json